These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35576973)

  • 1. Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders.
    Ye R; O'Callaghan C; Rua C; Hezemans FH; Holland N; Malpetti M; Jones PS; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe J
    Mov Disord; 2022 Aug; 37(8):1663-1672. PubMed ID: 35576973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.
    Ye R; Hezemans FH; O'Callaghan C; Tsvetanov KA; Rua C; Jones PS; Holland N; Malpetti M; Murley AG; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    J Neurosci; 2023 Oct; 43(42):7028-7040. PubMed ID: 37669861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson's Disease.
    Madelung CF; Meder D; Fuglsang SA; Marques MM; Boer VO; Madsen KH; Petersen ET; Hejl AM; Løkkegaard A; Siebner HR
    Mov Disord; 2022 Mar; 37(3):479-489. PubMed ID: 35114035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin-Sensitive Magnetic Resonance Imaging Changes in the Locus Coeruleus/Subcoeruleus Complex in Patients with Typical and Atypical Parkinsonism.
    Nobileau A; Gaurav R; Chougar L; Faucher A; Valabrègue R; Mangone G; Leu-Semenescu S; Lejeune FX; Corvol JC; Arnulf I; Vidailhet M; Grabli D; Degos B; Lehéricy S
    Mov Disord; 2023 Mar; 38(3):479-484. PubMed ID: 36592065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia.
    Matsuura K; Ii Y; Maeda M; Tabei KI; Satoh M; Umino M; Miyashita K; Ishikawa H; Shindo A; Tomimoto H
    Parkinsonism Relat Disord; 2021 Jun; 87():75-81. PubMed ID: 34000497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.
    Kaalund SS; Passamonti L; Allinson KSJ; Murley AG; Robbins TW; Spillantini MG; Rowe JB
    Acta Neuropathol Commun; 2020 Feb; 8(1):11. PubMed ID: 32019605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy.
    Klietz M; Mahmoudi N; Maudsley AA; Sheriff S; Bronzlik P; Almohammad M; Nösel P; Wegner F; Höglinger GU; Lanfermann H; Ding XQ
    Mov Disord; 2023 Aug; 38(8):1503-1514. PubMed ID: 37289057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.
    Lin CP; Frigerio I; Bol JGJM; Bouwman MMA; Wesseling AJ; Dahl MJ; Rozemuller AJM; van der Werf YD; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Transl Neurodegener; 2024 Feb; 13(1):9. PubMed ID: 38336865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
    Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
    Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.